Join
Live feed
·
INSIDERFilingvia Quantisnow
Lyell Immunopharma Inc. logo

President and CEO Seely Lynn sold $7,337 worth of shares (388 units at $18.91), decreasing direct ownership by 0.52% to 73,878 units (SEC Form 4) (tax withholding)

ByQuantisnow·Wall Street's wire, on your screen.
LYEL· Lyell Immunopharma Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track LYEL (Lyell Immunopharma Inc.) and more on Quantisnow.